Are robots racist? Should we regulate gene editing? Have people stopped trusting experts? Does scientific research make the world a more unequal place? The Received Wisdom is a podcast about how to realize the potential of science and technology by challenging the received wisdom. Join Shobita and Jack as they talk to thinkers and doers from around the world about governing science and technology to make the world a better place.
Episode 14: Equity in Science and Technology Policy and the Promise of Vaccines Featuring Maya Goldenberg
n this episode, Shobita and Jack talk about President Biden's plans for science and technology policy and his appointment of Alondra Nelson as Deputy Director for Science and Society in the White House Office of Science and Technology Policy, as well as the COVID-19 vaccine rollout in the United States and United Kingdom. And they chat with Maya Goldenberg, philosophy professor at the University of Guelph, about vaccine hesitancy and how it can be addressed.
Episode 13: Biden, Brexit, and the Future of Science and Technology Policy ft. Lina Dencik
It's a New Year, and may soon be a new world! Shobita and Jack discuss the big changes brewing in the US and UK, from the new president to Brexit, and consider what it all means for science and technology policy. And we chat with Lina Dencik, Professor and Director of the Data Justice Lab at Cardiff University.
- Lina Dencik (2019). "Social Justice in an Age of Datafication." Talk at the Alan Turing Institute. May 28.
- Lina Dencik,Arne Hintz, Joanna Redden & Emiliano Treré (2019). "Exploring Data Justice: Conceptions, Applications and Directions." Information, Communication, and Society. 22(7): 873-881.
- Javier Sánchez-Monedero and Lina Dencik (2020). "The politics of deceptive borders: ‘biomarkers of deceit’ and the case of iBorderCtrl." Information, Communication, and Society. 1-18.
- Javier Sánchez-Monedero, Lina Dencik, and Lilian Edwards (2020). "What does it mean to 'solve' the problem of discrimination in hiring?: social, technical and legal perspectives from the UK on automated hiring systems." FAT* '20: Proceedings of the 2020 Conference on Fairness, Accountability, and Transparency. pp. 458–468.
Vaccine Nationalism and How Artifacts Have Politics ft. Langdon Winner
Shobita and Jack reflect on the US election and the future of conservatism and exciting vaccine news, and speak with philosopher and STS forefather Langdon Winner about the politics of technology today. Winner recently released a new edition of his groundbreaking book, The Whale and the Reactor: A Search for Limits in an Age of High Technology.
Patent Activism, Access to Medicines, and The Social Dilemma ft. Priti Krishtel
Jack and Shobita discuss the growing politicization of COVID-19 science and at listeners' request, review the Netflix movie The Social DIlemma. And Shobita speaks with Priti Krishtel, co-executive director of the i-MAK, the Initiative for Medicines, Access, and Knowledge about how we can reform the patent system to make pharmaceuticals more affordable and accessible.
Envisioning a Just Future With or Without CRISPR ft. Ben Hurlbut
Shobita and Jack talk about how patents might shape access to a COVID-19 vaccine. And, in light of a recent report by the US and UK national scientific academies, we talk about heritable human genome editing (using CRISPR-Cas9) and the role that the world's citizens might play in deciding whether and how it might proceed, with Ben Hurlbut, Associate Professor in the School of Life Sciences at Arizona State University.
The New Politics of Big Tech, and Equity in Clinical Trials ft. Jill Fisher
Shobita and Jack discuss the recent US congressional hearings with the Big Tech CEOs, and the curious role that behavioral scientists have played in the UK's COVID-19 response. They also chat with Jill Fisher, Professor of Social Medicine at University of North Carolina--Chapel Hill and recent author of Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals, about the "healthy volunteers" who participate in clinical trials--including for COVID-19--and their exploitation.